Prospective Clinical Trial on the Impact of Uterine Fibromatosis Surgery on Pelvic Floor

What this Trial Is About

Uterine fibromatosis, a common gynecological condition affecting about 25-30% of women during their fertile years, is associated with symptoms like heavy menstrual bleeding, pelvic pain, and urinary or bowel issues. Risk factors include age, family history, and ethnicity, while multiple pregnancies, older age at pregnancy, and smoking may offer some protection. Despite many cases being symptom-free, uterine fibroids are a leading cause of hysterectomy for benign conditions, and their impact on urinary and pelvic floor symptoms remains unclear. This research observes women with symptomatic uterine fibromatosis who are scheduled for either hysterectomy or myomectomy surgery. The study evaluates how these surgical treatments affect pelvic floor function by measuring pelvic floor biometry at multiple points: before surgery, immediately after, and at 1, 6, and 12 months following surgery. The goal is to better understand the relationship between fibroid treatment and pelvic floor symptoms. Participants will undergo ultrasound mapping of their fibroids before surgery. Researchers will monitor pelvic floor health through repeated biometry assessments over the year following surgery. This study tracks changes in pelvic floor function over time to assess the impact of the surgical approach chosen. The total participation period lasts up to 12 months post-surgery, with careful monitoring of pelvic floor outcomes.

Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor.